Cargando…

Clinical efficacy of spray‐based heat‐treated lactobacilli in canine atopic dermatitis: a preliminary, open‐label, uncontrolled study

BACKGROUND: Canine atopic dermatitis (cAD) is a common inflammatory and pruritic skin disease, with various treatment options. The use of topical products containing natural ingredients has proven increasingly popular. OBJECTIVE: To evaluate the effects of a spray solution containing heat‐killed Lac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoro, Domenico, Fagman, Lana, Zhang, Yanping, Fahong, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Scientific Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048791/ https://www.ncbi.nlm.nih.gov/pubmed/33245188 http://dx.doi.org/10.1111/vde.12915

Ejemplares similares

Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification
por: Hensel, Patrick, et al.
Publicado: (2015)

Single-Strain Probiotic Lactobacilli for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis
por: Fijan, Sabina, et al.
Publicado: (2023)

Canine atopic dermatitis attenuated by mesenchymal stem cells
por: de Oliveira Ramos, Fernanda, et al.
Publicado: (2020)

Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis
por: Marsella, Rosanna, et al.
Publicado: (2020)

Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis
por: Chiocchetti, Roberto, et al.
Publicado: (2022)

The dynamics of the manifestations of atopic dermatitis in severe persistent uncontrolled asthma children with omalizumab therapy
por: Vishneva, Elena, et al.
Publicado: (2015)

Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis
por: Plant, Jon D., et al.
Publicado: (2017)

Canine atopic dermatitis: Role of luteolin as new natural treatment
por: Gugliandolo, Enrico, et al.
Publicado: (2020)

Sphingomyelin-Rich Lipid Extract Collar for Canine Atopic Dermatitis
por: Segarra, Sergi, et al.
Publicado: (2023)

Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension
por: Cork, M.J., et al.
Publicado: (2019)

Effect of indoor house dust mite concentration on canine atopic dermatitis
por: Kim, Jihee, et al.
Publicado: (2023)

Effect of Allergen-Specific Immunotherapy on Transcriptomic Changes in Canine Atopic Dermatitis
por: Majewska, Alicja, et al.
Publicado: (2023)

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis
por: Cosgrove, Sallie B, et al.
Publicado: (2013)

Off-label medications in the treatment of hospitalized children with atopic dermatitis
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

Local and Systemic Changes in Lipid Profile as Potential Biomarkers for Canine Atopic Dermatitis
por: Franco, Jackeline, et al.
Publicado: (2021)

Canine Mesenchymal-Stem-Cell-Derived Extracellular Vesicles Attenuate Atopic Dermatitis
por: Cho, Byong Seung, et al.
Publicado: (2023)

Immunomodulatory effects of canine mesenchymal stem cells in an experimental atopic dermatitis model
por: Kang, Seok-Jin, et al.
Publicado: (2023)

Primary Prevention of Canine Atopic Dermatitis: Breaking the Cycle—A Narrative Review
por: Fernandes, Beatriz, et al.
Publicado: (2023)

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
por: Little, Peter R, et al.
Publicado: (2015)

AN UNCONTROLLED OPEN PILOT STUDY TO ASSESS THE ROLE OF DIETARY ELIMINATIONS IN REDUCING THE SEVERITY OF ATOPIC DERMATITIS IN INFANTS AND CHILDREN
por: Dhar, Sandipan, et al.
Publicado: (2009)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Vitamin D and Atopic Dermatitis in Childhood
por: Vestita, Michelangelo, et al.
Publicado: (2015)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis
por: Cosgrove, Sallie B., et al.
Publicado: (2013)

Atopic dermatitis and indoor use of energy sources in cooking and heating appliances
por: Vicedo-Cabrera, Ana M, et al.
Publicado: (2012)

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial
por: Simpson, Eric L., et al.
Publicado: (2019)

Spontaneous resolution of atopic dermatitis incidental to participation in benralizumab clinical trial for severe, uncontrolled asthma: a case report
por: Pham, David N.
Publicado: (2021)

Establishing an experimental model for canine atopic dermatitis through epicutaneous application of Dermatophagoides farinae
por: Kim, Sang-Won, et al.
Publicado: (2022)

Bayesian model and selection signature analyses reveal risk factors for canine atopic dermatitis
por: Tengvall, Katarina, et al.
Publicado: (2022)

Pilot evaluation of a single oral fecal microbiota transplantation for canine atopic dermatitis
por: Sugita, Koji, et al.
Publicado: (2023)

Oral administration of lactobacilli isolated from Jeotgal, a salted fermented seafood, inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis in mice
por: Park, Mi-Sung, et al.
Publicado: (2017)

Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections
por: Spacova, Irina, et al.
Publicado: (2022)

A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy
por: Paller, A.S., et al.
Publicado: (2020)

Overview of atopic dermatitis
por: Kim, Kyu Han
Publicado: (2013)

Atopic dermatitis in adolescence
por: Ricci, Giampaolo, et al.
Publicado: (2011)

Prevention of atopic dermatitis
por: Williams, Hywel C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q7r3drmf9dnm6mbsa435e98k3e